Literature DB >> 2075623

Efficacy of three variations of periodic abstinence for family planning in Indonesia.

S Thapa1, M V Wonga, P G Lampe, H Pietojo, A Soejoenoes.   

Abstract

A prospective study to determine the efficacy of three alternative guidelines for the practice of periodic abstinence (PA) for family planning was conducted in Indonesia. The three methods studied were the Billings ovulation method, the Dorairaj modified mucus method, and a local version of the mucus method. For each method, the study encompassed a three-month learning phase and an additional 12-month effectiveness phase. Data from a total of 850 acceptors showed that, despite some variations in the sociodemographic characteristics of the acceptors, the Billings ovulation method had the lowest (10.4 per 100 women) and the local mucus method had the highest (26.5 per 100 women) overall life-table discontinuation rates in the effectiveness phase. One-year life-table unplanned pregnancy rates ranged from 2.5 per 100 women for the Billings method to a high of 11.5 per 100 women for the local method acceptors. Unplanned pregnancy was the main reason for termination.

Entities:  

Keywords:  Acceptor Characteristics; Acceptors; Asia; Cervical Mucus Method; Contraception; Contraception Termination; Data Analysis; Data Collection; Demographic Factors; Developing Countries; Economic Factors; Family Planning; Family Planning Programs; Family Planning, Behavioral Methods; Fertility; Fertility Measurements; Incidence; Indonesia; Knowledge; Measurement; Natural Family Planning; Population; Population Dynamics; Pregnancy Rate; Pregnancy, Unplanned; Prospective Studies; Reproductive Behavior; Research Methodology; Sexual Abstinence; Socioeconomic Factors; Southeastern Asia; Studies

Mesh:

Year:  1990        PMID: 2075623

Source DB:  PubMed          Journal:  Stud Fam Plann        ISSN: 0039-3665


  1 in total

Review 1.  Fertility awareness-based methods for contraception.

Authors:  D A Grimes; M F Gallo; V Grigorieva; K Nanda; K F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.